Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Eder

Showing results (61-70 of 163) with videos related to

Pageof 17
Sort By:
Chemico-Biological Interactions|February 1, 1982
Correlation of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigationE Eder, T Neudecker, D Lutz, et al.
Acta Medica Austriaca|January 1, 1978
[Stimulation of prolactin secretion by drugs]H Steininger, E Eder, O Sulm, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Studies on the spontaneous lymphocyte toxicity in colonic carcinoma]E Eder, E Mühe, G Kratzsch, et al.
Archives of Toxicology|July 19, 1977
Carcinogenicity of trichloroethylene: fact or artifact?D Henschler, E Eder, T Neudecker, et al.
Mutation Research|May 1, 1991
Genotoxic and cell-transforming properties of (trans,trans)-muconaldehydeD Henschler, E Eder, B Epe, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Rheumatologie|January 1, 1978
[90 Yttrium therapy in rheumatoid arthritis]J Teuber, G Regler, H W Baenkler, et al.
Future Oncology (London, England)|March 25, 2006
Targeting the androgen receptor in hormone-refractory prostate cancer--new conceptsIris E Eder, Petra Haag, Georg Bartsch, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 9, 2006
[Clinical consequences of androgen receptor malfunction]H Klocker, I E Eder, Z Culig, et al.
Current Gene Therapy|January 11, 2005
Gene therapy strategies in prostate cancerIris E Eder, Petra Haag, Georg Bartsch, et al.
Expert Reviews in Molecular Medicine|June 16, 2026
Dysregulation of the urea cycle - potential targets for treatment and diagnosis in prostate cancerMichael Ladurner, Helmut Klocker, Hannes Neuwirt, et al.
Pageof 17

Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Chemico-Biological Interactions|February 1, 1982
Correlation of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigationE Eder, T Neudecker, D Lutz, et al.
Acta Medica Austriaca|January 1, 1978
[Stimulation of prolactin secretion by drugs]H Steininger, E Eder, O Sulm, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Studies on the spontaneous lymphocyte toxicity in colonic carcinoma]E Eder, E Mühe, G Kratzsch, et al.
Archives of Toxicology|July 19, 1977
Carcinogenicity of trichloroethylene: fact or artifact?D Henschler, E Eder, T Neudecker, et al.
Mutation Research|May 1, 1991
Genotoxic and cell-transforming properties of (trans,trans)-muconaldehydeD Henschler, E Eder, B Epe, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Rheumatologie|January 1, 1978
[90 Yttrium therapy in rheumatoid arthritis]J Teuber, G Regler, H W Baenkler, et al.
Future Oncology (London, England)|March 25, 2006
Targeting the androgen receptor in hormone-refractory prostate cancer--new conceptsIris E Eder, Petra Haag, Georg Bartsch, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 9, 2006
[Clinical consequences of androgen receptor malfunction]H Klocker, I E Eder, Z Culig, et al.
Current Gene Therapy|January 11, 2005
Gene therapy strategies in prostate cancerIris E Eder, Petra Haag, Georg Bartsch, et al.
Expert Reviews in Molecular Medicine|June 16, 2026
Dysregulation of the urea cycle - potential targets for treatment and diagnosis in prostate cancerMichael Ladurner, Helmut Klocker, Hannes Neuwirt, et al.
Pageof 17